• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4665883)   Today's Articles (1054)   Subscriber (51713)
For: Wencel-Warot A, Michalak S, Warot M, Kalinowska-Lyszczarz A, Kazmierski R. The cross-reactivity of binding antibodies with different interferon beta formulations used as disease-modifying drugs in multiple sclerosis patients. Medicine (Baltimore) 2016;95:e5337. [PMID: 27828855 PMCID: PMC5106061 DOI: 10.1097/md.0000000000005337] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/30/2016] [Revised: 10/16/2016] [Accepted: 10/17/2016] [Indexed: 11/26/2022]  Open
Number Cited by Other Article(s)
1
Buron MD, Magyari M, Chalmer TA, Sørensen PS, Sellebjerg F. Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β. Mult Scler Relat Disord 2020;39:101894. [PMID: 31884382 DOI: 10.1016/j.msard.2019.101894] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2019] [Revised: 11/30/2019] [Accepted: 12/14/2019] [Indexed: 11/17/2022]
2
Shokrollahi Barough M, Ashtari F, Sadat Akhavi M, Asghari N, Mosayebi G, Mirmohammadkhani M, Kokhaei N, Bahraminia F, Ajami A, Kokhaei P. Neutralizing antibody production against Rebif® and ReciGen® in Relapsing-Remitting Multiple Sclerosis (RRMS) patients and its association with patient's disability. Int Immunopharmacol 2018;62:109-113. [PMID: 29990690 DOI: 10.1016/j.intimp.2018.06.032] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2018] [Revised: 06/03/2018] [Accepted: 06/22/2018] [Indexed: 12/15/2022]
3
Zettl UK, Hecker M, Aktas O, Wagner T, Rommer PS. Interferon β-1a and β-1b for patients with multiple sclerosis: updates to current knowledge. Expert Rev Clin Immunol 2018;14:137-153. [DOI: 10.1080/1744666x.2018.1426462] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA